Clinical Trial Update: Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of TLK199 tablets in patients with Myelodysplastic Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• TLK199

Snippet

Sponsor: Telik | Conditions: Myelodysplastic Syndrome (MDS) | Phase 1, Phase 2 | Status: COMPLETED